• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
Scope It Out
MENU 
  • Home
  • About IFAR
  • About Dr. Smith
  • Episodes
  • Subscribe

Episode 91: Spending, utilization, and coverage for chronic rhinosinusitis with nasal polyposis therapies among Medicare Advantage beneficiaries

August 8, 2024

In this episode, host Dr. Marc Dubin speaks with Dr. Vinay Rathi. They discuss the recently published Research Note: Spending, utilization, and coverage for chronic rhinosinusitis with nasal polyposis therapies among Medicare Advantage beneficiaries. Read the full article in the International Forum of Allergy and Rhinology.

Listen and subscribe for free to Scope It Out on Apple Podcasts, Google Podcasts and Subscribe on Android.

Scope It Out
Scope It Out
Episode 91: Spending, utilization, and coverage for chronic rhinosinusitis with nasal polyposis therapies among Medicare Advantage beneficiaries
Loading
00:00 / 18:05
Apple Podcasts
RSS Feed
Share
Link
Embed

Download file | Play in new window | Duration: 18:05 | Recorded on August 7, 2024

Subscribe: Apple Podcasts

Tagged With: chronic rhinosinusitis, dupilumab, Medicare, mepolizumab, nasal polyposis, omalizumab

Primary Sidebar

Visit Our Partners

American Academy of Otolaryngic AllergyInternational Forum of Allergy and RhinologyThe American Rhinologic Society

Sponsors

       Storz

  • Help & Support
  • About Us
  • Contact Us
  • Cookies & Privacy
  • Wiley Job Network
  • Cookie Preferences
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
Wiley